Furthermore, upon NF-κB activation, the enhanced expression of antiapoptotic genes, such as c-IAP, Survivin, Bcl-xL, MDR1, and MRP1 induced by NF-κB also contribute to tumor resistance. Here, BCL2L1 is linked to neoplasm.